The Indian patent office denied a drug patent application by U.S. pharmaceutical company Abbott Laboratories for the combination of lopinavir/ritonavir over the weekend, stating that the patenting was “not an invention.” The drug combination is a protease inhibitor used as a second line regimen to treat patients with HIV, and the patent denial opens the […]
HIV
Amid unprecedented challenges to routine healthcare access, trial results mark a first for a critically needed HIV prevention measure An investigational drug administered by injection every […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
What we have learned from HIV can guide responses to COVID-19 that are innovative, effective and inclusive, and can help end the pandemic faster The following […]
Policy
The following is a guest post by Kenneth G. Castro, MD, FIDSA Since its formation in 1948, WHO has relied heavily on the U.S. for collaborations […]